Targeting of cancer neoantigens with donor-derived T cell receptor repertoiresErlend Strønen, Ton N. Schumacher, Weiwen Yang et al.|Science|2016Cited by 448
Antigen‐specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapySander Kelderman, Nina Schumacher, Bianca Heemskerk et al.|European Journal of Immunology|2016Cited by 41